ULTRAVIST 370MG 50ML

ULTRAVIST 370MG 50ML is a contrast agent utilized in various medical imaging procedures, particularly in radiographic examinations such as computed tomography (CT) scans. It contains the active ingredient iopromide, which is a non-ionic, water-soluble radiopaque contrast medium. ULTRAVIST 370mg Injection is designed to enhance the visibility of internal body structures and organs during diagnostic imaging procedures.

Active Ingredient:

Iopromide: Iopromide is a radiopaque contrast agent that contains iodine, which absorbs X-rays and provides enhanced visibility of blood vessels, organs, and tissues during imaging procedures. It belongs to the class of non-ionic contrast media, which are associated with a lower risk of adverse reactions compared to ionic contrast agents.

Mechanism of Action:

Iopromide functions by increasing the attenuation of X-rays within the body, thereby improving the contrast between different tissues and enhancing the visibility of anatomical structures during radiographic imaging. It achieves this effect by containing iodine atoms that absorb X-rays, resulting in variations in X-ray attenuation and providing detailed images of the targeted area.

Uses:

ULTRAVIST 370mg Injection is indicated for use in various diagnostic imaging procedures to visualize internal body structures and organs, including:

• Computed Tomography (CT) scans: ULTRAVIST 370mg Injection is commonly used to enhance the contrast of blood vessels, organs, and tissues during CT scans of the head, chest, abdomen, and other body regions.
• Angiography: It may be employed in angiographic studies to visualize blood vessels and detect abnormalities such as arterial stenosis, aneurysms, or vascular malformations.
• Other Radiographic Examinations: ULTRAVIST 370mg Injection may be utilized in other radiographic procedures where contrast enhancement is necessary to improve diagnostic accuracy.

Dosage and Administration:

The dosage of ULTRAVIST 370mg Injection varies depending on the specific imaging procedure, patient factors such as weight and medical history, and the equipment used. It is typically administered intravenously at a controlled rate using an automated injector or manually by a healthcare professional. The dosage and administration protocol should be determined by the prescribing physician based on the individual patient’s needs and the imaging study being performed.

Side Effects:

Common side effects associated with ULTRAVIST 370mg Injection may include:

• Nausea
• Vomiting
• Flushing
• Headache
• Dizziness
• Injection site reactions (e.g., pain, warmth, redness)

Precautions:

• Patients with a history of iodine sensitivity or allergic reactions to contrast agents should be closely monitored for hypersensitivity reactions.
• Adequate hydration before and after contrast administration may reduce the risk of contrast-induced nephropathy, especially in patients with renal impairment.
• Special precautions should be taken in patients with a history of asthma, allergies, or renal dysfunction.
• ULTRAVIST 370mg Injection should be used with caution in pregnant or breastfeeding women, and the potential risks and benefits should be carefully considered.

Conclusion:

ULTRAVIST 370mg Injection is a radiographic contrast agent containing iopromide, commonly used in diagnostic imaging procedures such as CT scans and angiography to enhance the visibility of internal body structures. When used appropriately and under the guidance of healthcare professionals, ULTRAVIST 370mg Injection can provide valuable diagnostic information while minimizing the risk of adverse effects.